Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-20

Clinical Trial Update: Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating PedyPhar Ointment for diabetic foot ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pedyphar Ointment

Snippet

Sponsor: European Egyptian Pharmaceutical Industries | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: TERMINATED